Keyphrases
Human Brain
100%
Metformin
100%
Methylglyoxal
100%
SH-SY5Y Cells
100%
Neuronal Cells
100%
Dapagliflozin
100%
Peroxynitrite
27%
Cell Damage
27%
Type 1 Diabetes Mellitus (T1DM)
27%
Vascular Complications
18%
Copyright
18%
Antidiabetic Agents
18%
Protective Effect
9%
Incubation
9%
Cell Death
9%
Beneficial Effects
9%
Insulin Secretion
9%
Alzheimer's Disease
9%
Cytotoxicity
9%
Cell Injury
9%
Neuropathy
9%
Diabetic Patients
9%
Reactive Oxidant Species
9%
Neurodegenerative Diseases
9%
Blood Glucose
9%
LDH Assay
9%
MTT Assay
9%
Treatment Conditions
9%
Treatment Group
9%
Chronic Hyperglycemia
9%
Fluorescence Assay
9%
Laser Scanning Confocal Microscopy
9%
Dementia Risk
9%
Brain Cells
9%
Neurological Complications
9%
Condition Control
9%
Insulin Action
9%
Metabolic Disorders
9%
Neuroscience
Metformin
100%
Dapagliflozin
100%
Diabetes Mellitus
80%
Cell Damage
80%
Oxidizing Agent
20%
Alzheimer's Disease
20%
Cell Death
20%
Hyperglycemia
20%
Neurodegeneration
20%
Confocal Laser Scanning Microscopy
20%
Lactate Dehydrogenase
20%
Cytotoxicity
20%
MTT Assay
20%
Metabolic Disorder
20%
Neuropathy
20%
Pharmacology, Toxicology and Pharmaceutical Science
Metformin
100%
Methylglyoxal
100%
Dapagliflozin
100%
Diabetes Mellitus
36%
Peroxynitrite
27%
Antidiabetic Agent
18%
Oxidizing Agent
9%
Injury
9%
Lactate Dehydrogenase
9%
Confocal Microscopy
9%
Alzheimer's Disease
9%
Hyperglycemia
9%
Neuropathy
9%
Metabolic Disorder
9%
Fluorescence Assay
9%
Nerve Degeneration
9%
Neurological Complication
9%
Cytotoxicity
9%